The Implications of the Pandemic with Covid-19 in the Glycemic Control of People with Type 2 Diabetes.
Adriana GherbonMirela FrandesMarioara Nicula NeaguRomulus TimarBogdan TimarPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2023)
The findings of this study have demonstrated that in people with T2DM, the COVID-19 lockdown determines better glycemic control among patients treated with OAD compared to those treated with insulin therapy. Anxiety, stress, and emotions were the main reasons that led to the increase in glycemic values of these patients. Also, most patients have gained weight either due to lack of physical activity or due to stress.
Keyphrases
- glycemic control
- type diabetes
- coronavirus disease
- end stage renal disease
- sars cov
- physical activity
- newly diagnosed
- blood glucose
- chronic kidney disease
- ejection fraction
- weight loss
- peritoneal dialysis
- prognostic factors
- adipose tissue
- mesenchymal stem cells
- skeletal muscle
- depressive symptoms
- stress induced
- bone marrow
- weight gain
- patient reported